166 related articles for article (PubMed ID: 9201668)
1. Fluoxetine vs. tricyclic antidepressants in women with major depressive disorder.
Lewis-Hall FC; Wilson MG; Tepner RG; Koke SC
J Womens Health; 1997 Jun; 6(3):337-43. PubMed ID: 9201668
[TBL] [Abstract][Full Text] [Related]
2. Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis.
Beasley CM; Koke SC; Nilsson ME; Gonzales JS
Clin Ther; 2000 Nov; 22(11):1319-30. PubMed ID: 11117656
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
[TBL] [Abstract][Full Text] [Related]
4. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
Tollefson GD; Sayler ME
Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression.
Bech P; Cialdella P; Haugh MC; Birkett MA; Hours A; Boissel JP; Tollefson GD
Br J Psychiatry; 2000 May; 176():421-8. PubMed ID: 10912216
[TBL] [Abstract][Full Text] [Related]
8. Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.
Akhondzadeh S; Faraji H; Sadeghi M; Afkham K; Fakhrzadeh H; Kamalipour A
J Clin Pharm Ther; 2003 Oct; 28(5):379-84. PubMed ID: 14632962
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.
Baker B; Dorian P; Sandor P; Shapiro C; Schell C; Mitchell J; Irvine MJ
J Clin Psychopharmacol; 1997 Feb; 17(1):15-21. PubMed ID: 9004052
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine in tricyclic refractory major depressive disorder.
Beasley CM; Sayler ME; Cunningham GE; Weiss AM; Masica DN
J Affect Disord; 1990 Nov; 20(3):193-200. PubMed ID: 2148340
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
[TBL] [Abstract][Full Text] [Related]
12. Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine.
Lôo H; Saiz-Ruiz J; Costa e Silva JACE ; Ansseau M; Herrington R; Vaz-Serra A; Dilling H; de Risio S
J Affect Disord; 1999 Dec; 56(2-3):109-18. PubMed ID: 10701468
[TBL] [Abstract][Full Text] [Related]
14. Adverse events and treatment discontinuations in fluoxetine clinical trials.
Pande AC; Sayler ME
Int Clin Psychopharmacol; 1993; 8(4):267-9. PubMed ID: 8277146
[TBL] [Abstract][Full Text] [Related]
15. Predictors of response to amine-specific antidepressants.
Burns RA; Lock T; Edwards DR; Katona CL; Harrison DA; Robertson MM; Nairac B; Abou-Saleh MT
J Affect Disord; 1995 Dec; 35(3):97-106. PubMed ID: 8749837
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
17. Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdoses.
Revicki DA; Palmer CS; Phillips SD; Reblando JA; Heiligenstein JH; Brent J; Kulig K
Pharmacoeconomics; 1997 Jan; 11(1):48-55. PubMed ID: 10165526
[TBL] [Abstract][Full Text] [Related]
18. Paroxetine: an update of its use in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison.
Versiani M; Ontiveros A; Mazzotti G; Ospina J; Dávila J; Mata S; Pacheco A; Plewes J; Tamura R; Palacios M
Int Clin Psychopharmacol; 1999 Nov; 14(6):321-7. PubMed ID: 10565798
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
